Single-position ligand modifications tune CB₂R activity by targeting the toggle switch

Area of Science:

• Pharmacology
• Molecular Biology
• Medicinal Chemistry

Background:

• Cannabinoid receptor type 2 (CB₂R), a class A G protein-coupled receptor (GPCR), is a key therapeutic target for inflammatory conditions, pain, and neurodegenerative diseases.
• Developing selective ligands with tunable activity is crucial for effective therapeutic intervention.

Purpose of the Study:

• To design and synthesize novel CB₂R ligands based on the HU-308 scaffold with diverse sidechains.
• To investigate how structural modifications influence GPCR activation and functional outcomes.
• To explore the role of the CB₂R toggle switch residue (Trp258^6.48) in ligand-mediated modulation.

Main Methods:

• Synthesis of a series of ligands with a common scaffold and varied sidechains.
• Functional assays to assess ligand activity, including agonism, antagonism, and inverse agonism.
• Molecular dynamics simulations to elucidate the structural basis of ligand-receptor interactions.

Main Results:

• Structural modifications at a single position enabled precise control over CB₂R activity, achieving a spectrum of functional outcomes from full agonism to partial inverse agonism.
• Several low-efficacy ligands exhibited protean behavior, demonstrating context-dependent CB₂R modulation.
• A CF₃-substituted (S)-1 ligand showed distinct affinity, potency, and biased signaling, rationalized by molecular dynamics simulations indicating stabilization of an active conformation via interaction with the toggle switch.

Conclusions:

• Strategic modification of GPCR ligands, specifically targeting the toggle switch residue, can precisely modulate receptor activity across the efficacy spectrum.
• This approach offers a versatile strategy for developing tailored CB₂R modulators for therapeutic applications.
• Understanding ligand-receptor dynamics at the toggle switch is critical for designing biased agonists and optimizing therapeutic profiles.